Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases Conference Paper
| Authors: | Fong, Y.; Fortner, J.; Sun, R. L.; Brennan, M. F.; Blumgart, L. H. |
| Title: | Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases |
| Conference Title: | 119th Annual Meeting of the American Surgical Association |
| Abstract: | Objective: There is a need for clearly defined and widely applicable clinical criteria for the selection of patients who may benefit from hepatic resection for metastatic colorectal cancer. Such criteria would also be useful for stratification of patients in clinical trials for this disease. Methods: Clinical, pathologic, and outcome data for 1001 consecutive patients undergoing liver resection for metastatic colorectal cancer between July 1985 and October 1998 were examined. These resections included 237 trisegmentectomies, 394 lobectomies, and 370 resections encompassing less than a lobe. The surgical mortality rate was 2.8%. Results: The 5-year survival rate was 37%, and the 10-year survival rate was 22%. Seven factors were found to be significant and independent predictors of poor long-term outcome by multivariate analysis: positive margin (p = 0.004), extrahepatic disease (p = 0.003), node-positive primary (p = 0.02), disease-free interval from primary to metastases <12 months (p = 0.03), number of hepatic tumors >1 (p = 0.0004), largest hepatic tumor >5 cm (p = 0.01), and carcinoembryonic antigen level >200 ng/ml (p = 0.01). When the last five of these criteria were used in a preoperative scoring system, assigning one point for each criterion, the total score was highly predictive of outcome (p < 0.0001). No patient with a score of 5 was a long-term survivor. Conclusion: Resection of hepatic colorectal metastases may produce long-term survival and cure. Long- term outcome can be predicted from five criteria that are readily available for all patients considered for resection. Patients with up to two criteria can have a favorable outcome. Patients with three, four, or five criteria should be considered for experimental adjuvant trials. Studies of preoperative staging techniques or of adjuvant therapies should consider using such a score for stratification of patients. |
| Keywords: | adult; cancer survival; controlled study; treatment outcome; aged; aged, 80 and over; middle aged; survival rate; major clinical study; clinical feature; clinical trial; histopathology; cancer recurrence; patient selection; validation process; liver neoplasms; conference paper; lymph node metastasis; diagnostic accuracy; colorectal cancer; protein blood level; controlled clinical trial; neoplasm recurrence, local; tumor volume; carcinoembryonic antigen; prediction; time factors; colorectal neoplasms; liver metastasis; scoring system; predictive value of tests; multivariate analysis; cancer epidemiology; partial hepatectomy; humans; human; male; female; priority journal |
| Journal Title | Annals of Surgery |
| Volume: | 230 |
| Issue: | 3 |
| Conference Dates: | 1999 Apr 15-17 |
| Conference Location: | San Diego, CA |
| ISBN: | 0003-4932 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 1999-09-01 |
| Start Page: | 309 |
| End Page: | 321 |
| Language: | English |
| DOI: | 10.1097/00000658-199909000-00004 |
| PUBMED: | 10493478 |
| PROVIDER: | scopus |
| PMCID: | PMC1420876 |
| DOI/URL: | |
| Notes: | Conference Paper -- Export Date: 16 August 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work